The MOVE© Trial
A single-blind, randomised, placebo-controlled, parallel-group trial of the AusCAN Prevent © wheelchair re-positioning theory-based behaviour change program with real-time biofeedback of pressure injury risk – The MOVE© Trial.
This author has yet to write their bio.Meanwhile lets just say that we are proud Key2 contributed a whooping 6 entries.
A single-blind, randomised, placebo-controlled, parallel-group trial of the AusCAN Prevent © wheelchair re-positioning theory-based behaviour change program with real-time biofeedback of pressure injury risk – The MOVE© Trial.
Direct in vivo reprogramming of host astrocytes into functional neurons in the injured spinal cord
Pioneering research involving an APAC collaboration on the subject of spinal cord repair has attracted support from the Neurotrauma Research Program (NRP) and the Insurance Commission of WA (ICWA).
Perth, 8-11 December 2020
Perth: 16-18 May 2021